Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CCL19 is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Additionally we are shipping CCL19 Kits (65) and CCL19 Proteins (51) and many more products for this protein.
Showing 10 out of 115 products:
Human Polyclonal CCL19 Primary Antibody for IF (p), IHC (p) - ABIN740505
Borrelli, Abrão, Taube, Darb-Esfahani, Köhler, Kaufmann, Chiantera, Mechsner: Immunohistochemical Investigation of Metastasis-Related Chemokines in Deep-Infiltrating Endometriosis and Compromised Pelvic Sentinel Lymph Nodes. in Reproductive sciences (Thousand Oaks, Calif.) 2015
Interferon-gamma (IFN-gamma (show IFNG Antibodies)) and interleukin-12 (IL-12 (show IL12A Antibodies)) levels in the tumors and plasma were significantly enhanced after processing with recombinant mouse CCL19.
Modulation of the chemokines CCL19 and CCL21 (show CCL21 Antibodies) represents a potent immunoregulatory treatment approach, and thus represents a novel therapeutic target to stabilize atherosclerotic lesions.
CCL19 (ELC) improves TH1 (show HAND1 Antibodies)-polarized immune responses and protective immunity in a murine Her2/neu (show ERBB2 Antibodies) DNA vaccination model.
study shows that CCL19/21 and its possible signaling through CXCR3 (show CXCR3 Antibodies) are required for the development of thymic metallophilic macrophages
CCL19 and CCL21 (show CCL21 Antibodies) induce prompt Ab responses to antigen, and negatively regulate helper T cell responses in vivo.
CCX-CKR (show CCRL1 Antibodies)(-/-) have a 5-fold increase in the level of CCL21 (show CCL21 Antibodies) protein in blood, and 2- to 3-fold increases in CCL19 and CCL21 (show CCL21 Antibodies) in peripheral lymph nodes.
Complete deficiency of CCL19 & CCL21 (show CCL21 Antibodies) but not CCL19 alone was associated with abnormal frequencies & localization of DC in naive lymph nodes. CCL19 was not required for DC migration from the skin, full DC maturation or efficient T-cell priming.
Systemic delivery of an immune-activating signal using CCL19 transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer.
CCL19 homeostatic chemokine (show CCL1 Antibodies) performs distinct functions that cooperate with CCL21 (show CCL21 Antibodies) and CXCL13 (show CXCL13 Antibodies) to mediate effective expression of immunity against Mycobacterium tuberculosis infection.
CrkL (show CRKL Antibodies) regulates CCL19 and CCR7 (show CCR7 Antibodies)-induced epithelial-to-mesenchymal transition via ERK (show EPHB2 Antibodies) signaling pathway in epithelial ovarian carcinoma patients.
observed significantly higher concentrations of IL-8 (show IL8 Antibodies) (p < 0.001), MCP-1 (show CCL2 Antibodies) (p = 0.014), and MIP (show TNPO1 Antibodies)-3beta (p = 0.022) in the PF of women with endometriosis than in the controls.
The solution structure of CCL19 is reported. It contains a canonical chemokine (show CCL1 Antibodies) domain. Chemical shift mapping shows the N-termini of PSGL-1 (show SELPLG Antibodies) and CCR7 (show CCR7 Antibodies) have overlapping binding sites for CCL19 and binding is competitive.
Our findings serve to elucidate the molecular mechanisms underlying the resistin (show RETN Antibodies) induction of CCL19 expression in ECs and the shear-stress protection against this induction.
The pathogenesis of human prostate cancer may be mediated by the CCL19/CCR7 (show CCR7 Antibodies) axis.
The mRNA levels of CCL19/CCL21 (show CCL21 Antibodies) in ankylosing spondylitis hip ligament were significantly higher than in osteoarthritis ligament.
our data suggest that both CCL19 mRNA and protein were obviously expressed in a lower degree in HCC (show FAM126A Antibodies) tissues than adjacent non-tumorous liver tissues. The proliferation and migration of cells were distinctly suppressed by CCL19.
Serum CCL19 and CCL21 (show CCL21 Antibodies) were up-regulated during Rickettsia conorii infection.
CCL19 promoted monocyte adhesion to HUVEC cells. CCL19 rs2227302 was associated with coronary artery disease in a Chinese Han population.
CCL19 is an antimicrobial protein with bacteriocidal activity against E. coli.
This gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. It specifically binds to chemokine receptor CCR7.
C-C motif chemokine 19
, chemokine (C-C motif) ligand 19
, CCL19 chemokine
, CC chemokine ligand 19
, small inducible cytokine A19
, chemokine CCL19/MIP-3BETA
, CK beta-11
, EBI1 ligand chemokine
, EBI1-ligand chemokine
, beta chemokine exodus-3
, beta-chemokine exodus-3
, epstein-Barr virus-induced molecule 1 ligand chemokine
, macrophage inflammatory protein 3 beta
, macrophage inflammatory protein 3-beta
, small inducible cytokine subfamily A (Cys-Cys), member 19
, small-inducible cytokine A19
, EBI-1 ligand chemokine
, EBV-induced molecule 1 ligand chemokine
, chemokine CCL19